Robert F. Kennedy Jr.’s nomination to be Donald Trump’s health secretary has been dogged by his long record of anti-vaccine and anti-science statements. Even as Republicans embrace him as an ...

Merck’s 2025 guidance fell short of Wall Street expectations. - Spencer Platt/Getty Images Investors have taken to punishing pharma companies that appear unable to gauge demand for their top ...

Financial writer recommends Merck & Co., Inc. as a strong healthcare stock despite recent challenges, citing strong potential ...

Merck stock has shown some solid short-term strength, with its stock price of $98.90 comfortably sitting above its eight-day and 20-day simple moving averages (SMAs) of $97.81 and $98.64 ...

Elon Musk appears on the Time Magazine cover as 'President Musk' in an illustration done by the magazine as he and his Department of Government Efficiency gain strength in the administration.

The continued decline of Merck & Co.’s HPV vaccine Gardasil in China has come to a head as the New Jersey drug giant is halting shipments to the world’s second-most populous country.

Exactly eight years ago this week, Time magazine published a memorable cover story on Steve Bannon. The headline used for the piece inside the magazine asked, “Is Steve Bannon the Second Most ...

In a provocative move that could be aimed at stoking President Donald Trump’s ire, Time magazine’s latest print cover features Elon Musk behind the Resolute Desk in the Oval Office. The ...

Shares of global pharmaceutical company Merck (NYSE:MRK) fell 11% in the morning session after the company reported mixed fourth-quarter earnings. Its full-year revenue and EPS guidance missed by ...

Also Read: RJK Jr.'s Involvement In Merck Lawsuit Faces Scrutiny Ahead Of Senate Hearing The pharmaceutical unit booked $14.04 billion in revenue, up 7% year over year (+8% ex-exchange).

Merck operates in a highly competitive pharmaceutical landscape, particularly in oncology and PAH treatments. In the PAH space, the company faces competition from drugs such as Keros Therapeutics ...